Albumin Overview and Its Purification Method

Bushra Rehman; Hira Ikram; Rabia Nasir; Aiman Umar

doi:10.31703/gdddr.2023(VIII-II).12

Author(s)

Bushra Rehman Rahman Medical Institute, Peshawar, KP, Pakistan.

Hira Ikram Institute Biotechnology and Microbiology, Bacha Khan University, Charsadda, KP, Pakistan.

Rabia Nasir Center of Excellence in Marine Biology, Karachi, Sindh, Pakistan.

Aiman Umar Department of Microbiology, Quaid I Azam University, Islamabad, Pakistan.

Abstract

Drug researchers are currently studying the use of nanoparticles in drug delivery in great detail. In general, a medication's pharmacokinetic and tissue appropriation profiles can be changed, intracellular infiltration and appropriation can be improved, and a drug's absorption can be improved by dispersing the drug via the epithelium. The ability of nanoparticulate frameworks to tolerate physiological pressure-that is, their increased organic stability and oral conveyance plausibility-is one of their key advantages. As such, they offer a more appealing drug delivery solution than liposomes.

Publication Details

Page(s) 89-96

DOI 10.31703/gdddr.2023(VIII-II).12

Published Journal: Global Drug Design and Development Review, Volume: 8, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords

Nanoparticles, liposomes, Pharmacokinetic, Intracellular Infiltration

References

Suri S. S. H.,Fenniri B. .2007 .Singh, Nanotechnology-based drug delivery systems. J.Occup. Med. Toxicol. 1, : 2-16.

Roco M. C. .2003 .Nanotechnology: convergence with modern biology and medicine. Curr. Opin. Biotechnol, 14 : 337-346.

Torchilin V. P. .2008 .. , : .

Sahoo S. K. V. .2008 .Labhasetwar, Nanotech approaches to drug delivery and imaging. Drug Discov. Today, 8 : 1112-1120.

Couvreur P. C. .2006 .Vauthier, Nanotechnology: intelligent design to treat complex disease. Pharm. Res, 23 : 1417-1450.

Kumar R. M. N. .2000 .Nano and microparticles as controlled drug delivery devices. J.Pharm. Pharm. Sci. 3, : 234-258.

Liu Z,Jiao Y.,Wang Y.,Zhou C.,Z. Zhang. C. .2008 .Polysaccharides-based nanoparticlesas drug delivery systems. Adv. Drug Deliv. Rev, 60 : 1650-1662.

Fernandez-Urrusuno P.,Calvo C.,RemunanLopez L.,Vila-Jato M. J. .1999 .Alonso,Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res, 16 : 1576-1581.

Farrugia M. J. .1999 .Groves, the activity of unloaded gelatin nanoparticles on murine B16-F0 melanoma growth in vivo. Anticancer.Res, 19 : 1027-1031.

Fattal C.,Vauthier Y.,Nakada C.,Malvy P. .1998 .Couvreur, Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J. Control.Release, 53 : 137-143.

Breunig S.,Bauer A.,Pharm J. .2008 .Goepferich, Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur. , 68 : 112-128.

Kuijpers P.B. van Wachem,M.J.A. van Luyn L.A.,Brouwer G.H.M.,Engbers J. Krijgsveld .2000 .In vitro and in vivo evaluation of gelatin chondroitin sulphate hydrogels for controlled release of antibacterial proteins. Biomaterials, 21 : 1763-1772.

Elzoghby W.S. Abo,El-Fotoh N. A. .2011 .Elgindy, Casein-based formulations as promising controlled release drug delivery systems. J. Control. Release, 153 : 206-216.

Vandelli F.,Rivasi P.,Guerra F.,Forni R. .2001 .Arletti, Gelatin microspheres crosslinked with d, l-glyceraldehyde as a potential drug delivery system: preparation, characterization, in vitro and in vivo studies. Int. J. Pharm, 215 : 175-184.

Sahin H.,Selek M.T.,Ercan M.A.,Sargon A.,Hincal H.S. .2002 .Kas, Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. J. Control. Release, 82 : 345-358.

Langer S.,Balthasar V.,Vogel N.,Dinauer D. .2003 .Schubert Optimization of the preparation process for human serum albumin (HSA)nanoparticles. Int. J. Pharm, 257 : 169-180.

Rubino R.,Kowalsky J. .1993 .Swarbrick, Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking and drug release. Pharm. Res, 10 : 1059-1065.

Kommareddy M. .2005 .Amiji, Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug. Chem, 16 : 1423-1432.

Azarmi X.,Tao H.,Chen Z.,Wang W.H.,Finlay R.,Roa W.H. .2006 .Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powderaerosol particles. Int. J. Pharm, 319 : 155-161.

Kratz I. Fichtner,Schumarcher P.,T. P.,Feibig H.H.,Unger C. .1997 .Antitumoractivity of acid labile transferrin and albumin doxorubicin conjugates in vitro and in vivo human tumor xerograft models. Eur. J. Cancer, 33 : S175.

Abdolalizadeh J.,Majidi Z. J.,Nouri M.,Baradaran B.,Movassaghpour A.,Farajnia S. .1923 .Affi nity purification of tumor necrosis factoralpha expressed in raji cells by Produced scFvantibody coupled CNBr-activated sepharose. Adv Pharm Bull, 3(1) : .

Abdolalizadeh J.,Nouri M.,Zolbanin J. M,Baradaran B.,Barzegari A.,Omidi Y. .2012 .Downstream characterization of antiTNF-alpha single chain variable fragment antibodies. Hum Antibodies, 21(1-2) : 41-8.

Cuatrecasas P.,Wilchek M.,Anfinsen C. B. .1968 .Selective enzyme purification byaffinity chromatography. Proc Natl Acad Sci USA, 61(2) : 636-43.

Moore S.,Stein W. H. .1956 .Column chromatography of peptides and proteins. Adv. Protein Chem, 11 : 191-236.

William W.,Swiatek Gavin .2009 .. Current Analytical Chemistry, 5 : 000-000.

Kovacs A.,Guttman A. .2013 .Medicinal chemistry meets proteomics: Fractionation of the human plasma proteome. Curr Med Chem, 20(4) : 483-90.

Vasileva R.,Jakab M.,Hasko F. .1981 .Application of ionexchange chromatography for the production of human albumin. J Chromatogr, 216 : 279-84.

Abdolalizadeh J.,Majidi J.,Farajnia S. .2008 .Production and purification of polyclonal antibody against human kappa light chain. J Biol Sci, 8(3) : 683-6.

Aghebati M. A. .2013 .Large scale generation and characterization of anti-human cd34 monoclonal antibody in ascetic fluid of balb/c mice. Adv Pharm Bull, 3(1) : 211-6.

Frerick C.,Kreis P.,Gorak A.,Melzner D. .2006 .Simulation and optimisation of the downstream process for purification of human serum albumin by using ion exchange membrane adsorbers. Desalination, 200(1-3) : 468-9.

Frerick C.,Kreis P.,Gorak A.,Tappe A.,Melzner D. .2008 .Simulation of a human serum albumin downstream process incorporating ion-exchange membrane adsorbers. Chem Eng Process, 47(7) : 1128-38.

Ramin R.,Ali M.,Neda K.,Fatemeh S.,Sara S.,Jalal A. .2016 .Overview of protein ad its purification. Adv pharm bull, 6(4) : 495-507.

Denizli A. .2011 .Plasma fractionation: Conventional and chromatographic methods for albumin purification. Hacettepe J Biol Chem, 39(4) : 315-41.